BIO
Bio-Rad Laboratories A·NYSE
--
--(--)
--
--(--)
6.20 / 10
Outperform
Fund flow assessment is positive (6.2/10), reflecting robust money inflows across Small, Medium, and Large scales, although overall and block trends are negative. The sentiment score of 6.2 aligns with a Netural overall rating, indicating that while institutional inflows are healthy, broader market sentiment is mixed. This complements the technical weakness and underlines the need for careful timing.
Fund Flow Rating
Is money flowing into or out of BIO?
- BIO holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.20/10 (Outperform).
